Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Marta Guix"'
Autor:
Laura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, Josune Alonso-Marañón, Yolanda Guillén, Marta Guix, Irene Sangrador, Catalina Rozalén, Anna Vert, Antonio Barbachano, Joan Lop, Marta Salido, Beatriz Bellosillo, Raquel García-Romero, Marta Garrido, Jessica González, María Martínez-Iniesta, Erika López-Arribillaga, Ramón Salazar, Clara Montagut, Ferrán Torres, Mar Iglesias, Toni Celià-Terrassa, Alberto Muñoz, Alberto Villanueva, Anna Bigas, Lluís Espinosa
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
The failure of chemotherapy in colorectal cancer is currently unclear. Here, the authors show that upon sub-lethal dose of chemotherapy wild-type p53 colorectal cancers acquire a quiescence-like phenotype and a YAP-dependent fetal-like intestinal ste
Externí odkaz:
https://doaj.org/article/a95e4335e7804b569fac9baa390c372b
Autor:
María José Méndez-Vidal, Áurea Molina, Urbano Anido, Isabel Chirivella, Olatz Etxaniz, Eva Fernández-Parra, Marta Guix, Carolina Hernández, Julio Lambea, Álvaro Montesa, Álvaro Pinto, Silverio Ros, Enrique Gallardo
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects are linked to clinica
Externí odkaz:
https://doaj.org/article/722fb9affaea43eea50ec6bc3f06b33b
Autor:
Miren Taberna, Montserrat Torres, María Alejo, Marisa Mena, Sara Tous, Sandra Marquez, Miquel A. Pavón, Xavier León, Jacinto García, Marta Guix, Rafael Hijano, Teresa Bonfill, Antón Aguilà, Alicia Lozano, Ricard Mesía, Laia Alemany, Ignacio G. Bravo
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: Anti-epidermal-growth-factor-receptor (EGFR) therapies in combination with radiotherapy are being studied on de-escalation clinical trials for HPV-related oropharyngeal cancer (OPC) patients. The HPV16-E5 oncoprotein increases recycling o
Externí odkaz:
https://doaj.org/article/3c163deb796b4698b73b83a42ed031ca
Autor:
Miren Taberna, Marisa Mena, Sara Tous, Miquel Angel Pavón, Marc Oliva, Xavier León, Jacinto Garcia, Marta Guix, Rafael Hijano, Teresa Bonfill, Antón Aguilà, Laia Alemany, Ricard Mesía
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194107 (2018)
Given the different nature and better outcomes of oropharyngeal carcinoma (OPC) associated with human papillomavirus (HPV) infection, a novel clinical stage classification for HPV-related OPC has been accepted for the 8th edition AJCC TNM (ICON-S mod
Externí odkaz:
https://doaj.org/article/93780db7dcc944bfbc0b8e1568537cfb
Autor:
Martín, Esther Holgado, Cordellat, Ana Blasco, Arnau, Marta Guix, Roldán, Rosa Villatoro, Yagüe, Almudena Sanz, Martín, Diana Monge, Martínez, Fernando Caballero, Lucas, Francisco J. Campos, Castaño, Almudena García
Publikováno v:
In Seminars in Oncology December 2023 50(6):149-154
Autor:
Joana, Vidal, Maria Concepción, Fernández-Rodríguez, David, Casadevall, Pilar, Garcia-Alfonso, David, Páez, Marta, Guix, Vicente, Alonso, María Teresa, Cano, Cristina, Santos, Gema, Durán, Elena, Élez, Jose Luis, Manzano, Rocio, Garcia-Carbonero, Reyes, Ferreiro-Monteagudo, Ferran, Losa, Estela, Pineda, Javier, Sastre, Fernando, Rivera, Beatriz, Bellosillo, Josep, Tabernero, Enrique, Aranda, Ramon, Salazar, Clara, Montagut
Publikováno v:
Clinical Cancer Research. 29:379-388
Purpose: Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b7bf7cc7ab8db21a0bbb743f6c3405
https://doi.org/10.1158/1078-0432.ccr-22-1696
https://doi.org/10.1158/1078-0432.ccr-22-1696
Autor:
Clara Montagut, Ramon Salazar, Enrique Aranda, Josep Tabernero, Beatriz Bellosillo, Fernando Rivera, Javier Sastre, Estela Pineda, Ferran Losa, Reyes Ferreiro, Rocío Garcia-Carbonero, José Luís Manzano, Elena Elez, Gema Durán, Cristina Santos, Maria Teresa Cano, Vicente Alonso, Marta Guix, David Páez, Pilar García-Alfonso, David Casadevall, Maria Concepción Fernández-Rodríguez, Joana Vidal
Purpose:Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed11c20d1556270e0bfe4b1c0086745
https://doi.org/10.1158/1078-0432.c.6532748.v1
https://doi.org/10.1158/1078-0432.c.6532748.v1
Autor:
Clara Montagut, Ramon Salazar, Enrique Aranda, Josep Tabernero, Beatriz Bellosillo, Fernando Rivera, Javier Sastre, Estela Pineda, Ferran Losa, Reyes Ferreiro, Rocío Garcia-Carbonero, José Luís Manzano, Elena Elez, Gema Durán, Cristina Santos, Maria Teresa Cano, Vicente Alonso, Marta Guix, David Páez, Pilar García-Alfonso, David Casadevall, Maria Concepción Fernández-Rodríguez, Joana Vidal
Supplementary Tables 1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f5de4d541efee4733f8c21aaea3489
https://doi.org/10.1158/1078-0432.22488512.v1
https://doi.org/10.1158/1078-0432.22488512.v1
Autor:
Carlos L. Arteaga, Craig W. Lindsley, J. Phillip Kennedy, Gordon B. Mills, Bryan T. Hennessy, Ana M. Gonzalez-Angulo, Gizeh Pérez-Tenorio, Olle Stål, Marta Guix, Archana Narasanna, Marianela Pérez-Torres, Todd W. Miller
Supplementary Methods from Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2636c64be43ad54de87ade6e171fbec2
https://doi.org/10.1158/0008-5472.22379066
https://doi.org/10.1158/0008-5472.22379066
Autor:
Carlos L. Arteaga, Craig W. Lindsley, J. Phillip Kennedy, Gordon B. Mills, Bryan T. Hennessy, Ana M. Gonzalez-Angulo, Gizeh Pérez-Tenorio, Olle Stål, Marta Guix, Archana Narasanna, Marianela Pérez-Torres, Todd W. Miller
Knockdown of the tumor suppressor phosphatase Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) with shRNA in three estrogen receptor (ER)-positive breast cancer cell lines resulted in increased phosphatidylinositol-3 kinase (PI3K) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da449ae2c520440e874fd8d757847d76
https://doi.org/10.1158/0008-5472.c.6499121.v1
https://doi.org/10.1158/0008-5472.c.6499121.v1